| Financial Year |
March 31 2023 |
| Monetary Funds |
1,163,783,627.39 |
| Held-for-trading Financial Assets |
65,096,589.05 |
| Notes Receivable |
9,035,707.62 |
| Accounts Receivable |
271,503,842.67 |
| Advances to Suppliers |
92,899,005.07 |
| Other Receivables |
9,498,268.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
38,197,270.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,592,895.03 |
| Total Current Assets |
2,465,662,148.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,088,747.72 |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,533,722.13 |
| Fixed Assetes |
59,147,389.86 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,448,545.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
36,446,483.24 |
| Other Non-Current Assets |
124,557,018.90 |
| Sub-Total of Non-Current Assets |
254,032,932.67 |
| Total Assets |
2,719,695,081.31 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,000,000.00 |
| Accounts Payable |
670,732,271.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,363,096.46 |
| Taxes Payable |
63,429,215.97 |
| Interest Payable |
-- |
| Dividend Payable |
53,340,000.00 |
| Other payables |
55,745,213.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,466,511.51 |
| Other Current Liabilities |
54,346,468.85 |
| Sub-Total of Current Liabilities |
1,547,504,708.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,561,550.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,553,366.58 |
| Total Liabilities |
1,552,058,075.25 |
| Paid-In Capital(Or Share Stock) |
213,360,000.00 |
| Capital Surplus |
256,201,716.58 |
| Surplus Reserve |
99,828,006.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
577,973,606.15 |
| Minority Stockholder's Interest |
17,870,575.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,149,766,430.12 |
| Owner's Equity（Stockholder's Equity） |
1,167,637,006.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,719,695,081.31 |
